Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.


Pharmaceutical

Allarity Therapeutics

Thomas Jensen

Bruce Pratt

Steen Knudsen

Marie Foegh

Joan Brown

Ulrik Christensen

Oncology Venture's Board of Directors includes Gail Maderis and 2 others.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Allarity Therapeutics

Leadership Team

CEO and Executive Team